Concurrences Foreign Direct Investment Guide

The EU e-Evidence Regulation has entered into force, establishing a new framework for cross-border requests for electronic evidence in criminal proceedings. Service providers operating in the EU now face strict compliance deadlines and significant penalties for non-compliance, while navigating complex rules about data production, preservation orders, and limited grounds for refusal. How will companies balance law enforcement cooperation with fundamental rights protections under this challenging new regime?

Ireland launches its first National Anti-Money Laundering Strategy for 2026-2030, introducing comprehensive reforms to combat financial crime including enhanced crypto-asset regulations, expanded beneficial ownership transparency, and strengthened supervision across high-risk sectors.

Preparation of this Strategy closely follows on from the recently published National Risk Assessment on Money Laundering, Terrorist Financing and Proliferation Financing 2026 and its associated Priority Action Implementation Plan...

Dillon Eustace launches a comprehensive Anti-Money Laundering Hub to guide companies through the EU's most significant AML/CFT framework reform. The resource centre provides practical guidance on the new EU AML Package, including AMLR, AMLD6, and the establishment of AMLA, as organizations prepare for substantial changes taking effect in July 2027.

Ireland's Critical Infrastructure Act 2026 introduces a new legal framework requiring public bodies to prioritise and expedite delivery of State-funded infrastructure projects designated as critical by the Government. The Act establishes ministerial oversight powers, coordination duties, and resource allocation requirements while notably exempting designated projects from certain climate action obligations.

Adoption of a proposal by the European Commission for a Public Procurement Act to revise the Public Procurement Directives has been rescheduled to September 2026.

The EU continues its ambitious reform agenda for life sciences regulation, with landmark agreements on pharmaceutical legislation and biotech innovation frameworks. Ireland's Council Presidency is set to drive progress on critical medicines legislation and medical device reforms, while new investment initiatives aim to mobilize billions into Europe's biotech sector.

The European Union's evolving regulatory landscape for artificial intelligence, cybersecurity, and health data is creating new compliance challenges and opportunities for life sciences organizations. From the AI Act's refinements to the delayed NIS2 Directive transposition in Ireland, stakeholders must navigate multiple intersecting frameworks while preparing for the European Health Data Space Regulation's implementation.

Ireland assumes the Presidency of the Council of the European Union at a pivotal moment, with a six-month agenda centered on competitiveness, values, and security. The programme emphasizes simplification of existing frameworks, resilience across critical sectors, and preparation for the EU's next long-term investment cycle through 2034.

Ireland is preparing to implement the EU's e-Evidence Package through new legislation that will establish the Office of Director of Criminal Justice International Cooperation (CJICO), creating one of the EU's busiest justice coordination hubs.